文献速递儿童呼吸儿童感染

呼吸道病毒与儿童哮喘急性发作治疗失败的关系

Respiratory Viruses and Treatment Failure in Children With Asthma Exacerbation.
PubMed 文献 · Pediatrics · 2018-06-04

该研究为DOORWAY前瞻性队列的二次分析,纳入958例1-17岁至急诊就诊的中重度哮喘急性发作患儿,用RT-PCR检测27种呼吸道病原。任何病原阳性与就诊时严重度无关,但治疗失败风险更高(20.7% vs 12.5%,RD=8.2%),非鼻病毒病原、呼吸道合胞病毒、流感病毒和副流感病毒的治疗失败风险增加更明显。

要点

  • 病原阳性不增加就诊时严重度,但治疗失败风险增加8.2%。
  • 非鼻病毒病原、呼吸道合胞病毒、流感病毒和副流感病毒与治疗失败风险增加相关。
  • 提示哮喘患儿应预防流感,就诊时可考虑病原鉴定并探索强化治疗。

核心结论

  • 呼吸道病原与哮喘急性发作就诊时严重度无关,但与标准化治疗失败风险增加相关。
  • 非鼻病毒病原、呼吸道合胞病毒、流感病毒和副流感病毒与治疗失败风险增加相关。

研究设计与样本

  • DOORWAY前瞻性队列研究的二次分析,纳入958例1-17岁至急诊就诊的中重度哮喘急性发作患儿。
  • 鼻咽标本用RT-PCR检测27种呼吸道病原,采用多因素logistic回归估计平均边际效应(绝对风险和风险差)。

主要发现

  • 61.7%的患儿检出至少1种病原,鼻病毒最常见(29.4%),16.9%的患儿发生治疗失败。
  • 任何病原阳性与就诊时严重度无关,但与治疗失败风险增加相关(20.7% vs 12.5%;RD=8.2%[95%CI:3.3%至13.1%])。
  • 非鼻病毒病原与治疗失败绝对风险增加13.1%(95%CI:6.4%至19.8%)相关。
  • 呼吸道合胞病毒、流感病毒和副流感病毒分别与治疗失败风险增加8.8%、24.9%和34.1%相关。

关键数值与推荐

  • 治疗失败定义为住院、急诊停留超过8小时或复发。
  • 严重度用儿童呼吸评估量表(PRAM)评估。

临床怎么用

  • 对哮喘急性发作患儿,病原阳性不提示就诊时更重,但应警惕治疗失败风险升高。
  • 流感病毒、呼吸道合胞病毒和副流感病毒感染的患儿治疗失败风险更高,可考虑病原鉴定并探索强化治疗。
  • 支持对哮喘患儿进行流感预防。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: : media-1vid110.1542/5771275574001PEDS-VA_2017-4105Video Abstract OBJECTIVES: Respiratory pathogens commonly trigger pediatric asthma exacerbations, but their impact on severity and treatment response remains unclear. METHODS: We performed a secondary analysis of the Determinants of Oral Corticosteroid Responsiveness in Wheezing Asthmatic Youth (DOORWAY) study, a prospective cohort study of children (aged 1-17 years) presenting to the emergency department with moderate or severe exacerbations. Nasopharyngeal specimens were analyzed by RT-PCR for 27 respiratory pathogens. We investigated the association between pathogens and both exacerbation severity (assessed with the Pediatric Respiratory Assessment Measure) and treatment failure (hospital admission, emergency department stay >8 hours, or relapse) of a standardized severity-specific treatment. Logistic multivariate regressions were used to estimate average marginal effects (absolute risks and risk differences [RD]). RESULTS: Of 958 participants, 61.7% were positive for ≥1 pathogen (rhinovirus was the most prevalent [29.4%]) and 16.9% experienced treatment failure. The presence of any pathogen was not associated with higher baseline severity but with a higher risk of treatment failure (20.7% vs 12.5%; RD = 8.2% [95% confidence interval: 3.3% to 13.1%]) compared to the absence of a pathogen. Nonrhinovirus pathogens were associated with an increased absolute risk (RD) of treatment failure by 13.1% (95% confidence interval: 6.4% to 19.8%), specifically, by 8.8% for respiratory syncytial virus, 24.9% for influenza, and 34.1% for parainfluenza. CONCLUSIONS: Although respiratory pathogens were not associated with higher severity on presentation, they were associated with increased treatment failure risk, particularly in the presence of respiratory syncytial virus, influenza, and parainfluenza. This supports influenza prevention in asthmatic children, consideration of pathogen identification on presentation, and exploration of treatment intensification for infected patients at higher risk of treatment failure.

来源:Pediatrics,查看原文。版权归原作者所有。

引用

  1. Merckx J, Ducharme FM, Martineau C, et al. Respiratory Viruses and Treatment Failure in Children With Asthma Exacerbation. Pediatrics. 2018. PMID: 29866794. doi:10.1542/peds.2017-4105

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。